We have located links that may give you full text access.
Influence of cold water face immersion on post-exercise parasympathetic reactivation.
European Journal of Applied Physiology 2010 Februrary
The aim of the present study was to investigate the effect of cold water face immersion on post-exercise parasympathetic reactivation, inferred from heart rate (HR) recovery (HRR) and HR variability (HRV) indices. Thirteen men performed, on two different occasions, an intermittent exercise (i.e., an all-out 30-s Wingate test followed by a 5-min run at 45% of the speed reached at the end of the 30-15 Intermittent Fitness test, interspersed with 5 min of seated recovery), randomly followed by 5 min of passive (seated) recovery with either cold water face immersion (CWFI) or control (CON). HR was recorded beat-to-beat and vagal-related HRV indices (i.e., natural logarithm of the high-frequency band, LnHF, and natural logarithm of the square root of the mean sum of squared differences between adjacent normal R-R intervals, Ln rMSSD) and HRR (e.g., heart beats recovered in the first minute after exercise cessation) were calculated for both recovery conditions. Parasympathetic reactivation was faster for the CWFI condition, as indicated by higher LnHF (P = 0.004), Ln rMSSD (P = 0.026) and HRR (P = 0.002) values for the CWFI compared with the CON condition. Cold water face immersion appears to be a simple and efficient means of immediately accelerating post-exercise parasympathetic reactivation.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app